Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.

Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 added. The prior funding-status notice was removed; no changes were made to core study information.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide government funding and operation status notice and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedUI/metadata updates were introduced: a glossary display option is now shown, and the QC-related label Last Update Submitted that Met QC Criteria appears alongside a revision note showing v3.4.0 (with No FEAR Act Data wording adjusted). No changes were made to core study content, eligibility criteria, or outcomes.SummaryDifference0.2%

- Check84 days agoChange DetectedThe Locations section now lists Minnesota as a study site. The Minnesota Locations entry and the HHS Vulnerability Disclosure section were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check106 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.